Annual Meeting

A good place to live and to study cancer

Jason Liu
By Jason Liu
Oct. 27, 2023

After completing my postdoctoral training at the University of California, San Diego, I received an attractive offer to work in San Antonio. I am now an associate professor in the molecular medicine department at the University of Texas Health Science Center at San Antonio.

Dynamic control of enhancer repertoires drives stage-specific transcription during tissue development and disease progression. My lab’s overall objective is to gain a fundamental understanding of the regulations of enhancer dynamics in response to signaling and their effects on gene regulation, leading to innovative approaches to prevent and treat enhancer-related diseases, especially cancers.

I wanted to work in this city for several reasons. First, Texas offers substantial start-up funding for researchers across various disciplines to study cancer. As a new PI who recently concluded postdoctoral training and was recruited as a tenure-track faculty member, I received a $2 million start-up grant from the Cancer Prevention and Research Institute of Texas, known as CPRIT. Also, San Antonio is a military city and many people choose to stay after retiring. This ensures abundant clinical resources for researching aging and cancer.

San Antonio also has historical significance and is a vibrant tourist destination, with attractions such as the River Walk and the Alamo. As the seventh-largest city in the U.S., San Antonio offers the advantages of a major urban center while providing a high quality of life due to its affordability and favorable traffic conditions.

My wife is also a PI, researching neuronal diseases. She and I have been immensely content working and living in San Antonio since we moved here from San Diego. Our two young daughters find a lot of fun things to do in this city. Besides working hard in the lab, we often take our daughters out to eat good food, visit the attractions and play at the SeaWorld or Six Flags amusement parks on weekends.  

Submit an abstract

Discover BMB, the annual meeting of the American Society for Biochemistry and Molecular Biology, will be held March 23–26 in San Antonio. Abstracts for poster presentations and spotlight talks will be accepted through Nov. 30. See the poster categories and spotlight talk themes.

Enjoy reading ASBMB Today?

Become a member to receive the print edition monthly and the digital edition weekly.

Learn more
Jason Liu
Jason Liu

Jason Liu is an associate professor in the molecular medicine department at the University of Texas Health Science Center at San Antonio.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in People

People highlights or most popular articles

Gary Felsenfeld (1929–2024)
Retrospective

Gary Felsenfeld (1929–2024)

July 15, 2024

Three colleagues remember a researcher whose work at the NIH revealed the dynamic nature of chromatin and its role in gene expression and epigenetic regulation.

Getting to the genetic basis of cardiovascular disease
Journal News

Getting to the genetic basis of cardiovascular disease

July 11, 2024

Edwin G. Peña Martínez received a JBC Tabor award for associating the condition with mutations in noncoding sequences.

Protein Society announces awards
Member News

Protein Society announces awards

July 8, 2024

ASBMB members Neil Kelleher, Alexandra Newton, David Craik, David Cortez and Jeffery W. Kelly are among the honorees.

In memoriam: Herbert Cheung
In Memoriam

In memoriam: Herbert Cheung

July 8, 2024

He was a biochemist who specialized in the use of fluorescence technology and had been a member of the ASBMB since 1972.

Inspired by science — and passing it on
Research Spotlight

Inspired by science — and passing it on

July 3, 2024

Adriana Norris started a YouTube channel to take some of the mystery out of academia.

'Simple things can go wrong and cause disease'
Award

'Simple things can go wrong and cause disease'

July 2, 2024

Cancer biologist Jenny Hogstrom received a JBC Tabor award for her use of organoids to study drug resistance in cancer.